These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 7047826)
41. Eicosapentaenoic acid inhibits the release of 14C-prostacyclin from a perfused tissue after incorporation of 14C-prostaglandin precursors. Juan H; Sametz W Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):388-93. PubMed ID: 2993925 [TBL] [Abstract][Full Text] [Related]
42. Metabolism of arachidonic acid and its endoperoxide (PGH2) to myotropic products in guinea-pig and rabbit isolated lungs. Alabaster VA Br J Pharmacol; 1980 Jul; 69(3):479-89. PubMed ID: 7397457 [TBL] [Abstract][Full Text] [Related]
43. Inhibition by nicotine of the vasodilator effect of bradykinin: evidence for a prostacyclin-dependent mechanism. Türker RK; Ercan ZS; Ersoy A; Zengil H Arch Int Pharmacodyn Ther; 1982 May; 257(1):94-103. PubMed ID: 7052005 [TBL] [Abstract][Full Text] [Related]
44. Effect of lung transit on systemic depressor responses to arachidonic acid and prostacyclin in dogs. Waldman HM; Alter I; Kot PA; Rose JC; Ramwell PW J Pharmacol Exp Ther; 1978 Feb; 204(2):289-93. PubMed ID: 340641 [TBL] [Abstract][Full Text] [Related]
45. [Effects of prostacyclin on the cardiac functions and energy metabolism in the perfused rat heart]. Takeuchi S Hokkaido Igaku Zasshi; 1985 May; 60(3):355-67. PubMed ID: 3894189 [TBL] [Abstract][Full Text] [Related]
46. Prostanoid release from ex vivo perfused canine arteries and veins: effects of prolonged perfusion, intermittent perfusion, as well as exposure to exogenous arachidonic acid, thrombin and bradykinin. Brunkwall JS; Stanley JC; Kresowik TF; Graham LM; Burkel WE; Bergqvist D Thromb Haemost; 1989 Nov; 62(3):1034-9. PubMed ID: 2512675 [TBL] [Abstract][Full Text] [Related]
47. Evidence for functionally distinct pools of phospholipase responsible for prostaglandin release from the perfused guinea-pig lung. Robinson C; Hoult JR Eur J Pharmacol; 1980 Jun; 64(4):333-9. PubMed ID: 7389826 [TBL] [Abstract][Full Text] [Related]
48. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney. Rump LC; Schollmeyer P Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228 [TBL] [Abstract][Full Text] [Related]
49. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig. Dusting GJ; Moncada S; Vane JR Eur J Pharmacol; 1977 Oct; 45(3):301-4. PubMed ID: 336382 [TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase products and cyclic nucleotide levels with infusion of arachidonic acid, PGI2, PGE2, PGF2, and 6-keto-PGF1 in an isolated dog lung. Littner M; Kazmi G; Lott F; Golub M; Berger M Am Rev Respir Dis; 1983 Nov; 128(5):868-74. PubMed ID: 6314861 [TBL] [Abstract][Full Text] [Related]
52. Prostaglandin involvement in hypersensitivity of ischemic hearts to arrhythmogenic influence of ouabain. Moffat MP; Karmazyn M; Ferrier GR Am J Physiol; 1985 Jul; 249(1 Pt 2):H57-63. PubMed ID: 3925797 [TBL] [Abstract][Full Text] [Related]
53. Augmented thromboxane generation by mesenteric arteries from pancreatectomized diabetic dogs is coincident with the vascular tone enhancement evoked by Na arachidonate and prostacyclin. Sterin-Borda L; Franchi AM; Borda ES; Del Castillo E; Gimeno MF; Gimeno AL Eur J Pharmacol; 1984 Aug; 103(3-4):211-21. PubMed ID: 6436040 [TBL] [Abstract][Full Text] [Related]
54. Postconditioning and intermittent bradykinin induced cardioprotection require cyclooxygenase activation and prostacyclin release during reperfusion. Penna C; Mancardi D; Tullio F; Pagliaro P Basic Res Cardiol; 2008 Jul; 103(4):368-77. PubMed ID: 18188493 [TBL] [Abstract][Full Text] [Related]
55. A preliminary study of prostaglandin release by bradykinin (BK) on isolated human myometrium. Abbas F; Clayton J; Marshall K; Senior J Immunopharmacology; 1996 Jun; 33(1-3):130-2. PubMed ID: 8856131 [TBL] [Abstract][Full Text] [Related]
56. Effect of adenosine on the formation of prostacyclin in the rabbit isolated heart. Karwatowska-Prokopczuk E; Ciabattoni G; Wennmalm A Br J Pharmacol; 1988 Jul; 94(3):721-8. PubMed ID: 3052678 [TBL] [Abstract][Full Text] [Related]
57. Characterization of the arachidonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. Taiwo YO; Levine JD Brain Res; 1988 Aug; 458(2):402-6. PubMed ID: 3061568 [TBL] [Abstract][Full Text] [Related]
58. Pericardial release of prostacyclin induced by bradykinin and angiotensin II: effects on coronary blood flow in the dog. Woodman OL; Dusting GJ; Nolan RD J Cardiovasc Pharmacol; 1983; 5(6):954-60. PubMed ID: 6196567 [TBL] [Abstract][Full Text] [Related]
59. The endothelium-dependent and the endothelium-independent vasodilators in the isolated, perfused guinea pig heart. Chłopicki S; Gryglewski RJ J Physiol Pharmacol; 1992 Dec; 43(4):353-65. PubMed ID: 1294266 [TBL] [Abstract][Full Text] [Related]
60. Calcium paradox-evoked release of prostacyclin and immunoreactive leukotriene C4 from rat and guinea-pig hearts. Evidence that endogenous prostaglandins inhibit leukotriene biosynthesis. Karmazyn M J Mol Cell Cardiol; 1987 Mar; 19(3):221-30. PubMed ID: 3110422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]